Immune response to SARS-CoV-2 Omicron variant in patients and vaccinees following homologous and heterologous vaccinations | Communications Biology - Nature.com

Antibodies elicited by a triple homologous or heterologous vaccination regimen or following natural SARS-CoV-2 infection combined with a two-dose vaccine course, result in highest neutralization capacity against the Omicron variant BA.1.
The SARS-CoV-2 Omicron variant has rapidly replaced the Delta VOC in most European countries and, as anticipated by the World Health Organization, it is expected to display more than 50% seroprevalen… [+10540 chars] Read More